REICHE, DANIA BIRTE,MOHREN, NICOLE,JOHNSTON, LAURA,SOMMERVILLE, BRUCE,VOTH, REBECCA K.
申请号：
CA2943704
公开号：
CA2943704A1
申请日:
2015.03.30
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.
